Naxions, a Chinese provider of digital marketing solutions for pharmaceutical companies, has completed a US$15 million series B round of financing led by the country’s venture capital firm Volcanics Venture and China Creation Ventures (CCV), according to a statement released on Monday.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
